Alphyn Biologics, Inc.
PrivateLast Round
Series B
Dec 12, 2025
Est. Valuation
$42.8M
Total Funding Raised
$31.78M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Alphyn Biologics, Inc. is a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics for severe and prevalent skin diseases based on its proprietary Zabalafin Platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alphyn Biologics, Inc. Comparables
Compare Alphyn Biologics, Inc. with similar companies based on industry and business-model similarity.
Alphyn Biologics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 12, 2025 | ||||
| Series B | Jan 4, 2023 | ||||
| Series A | Sep 15, 2022 | ||||
| Seed | Jun 30, 2021 | ||||
| Seed | Mar 1, 2020 |
Alphyn Biologics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Serial Stage Venture Partners | Series B, Series A |
| QCA Ventures | Series B, Series A |
| VisionTech Partners | Series B |
| QCA Ventures | Series B |
| Angel Physicians Fund | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors grew 618% MoM, from 285 to 2K.
- Dec 12, 2025
$25M round completed.
Alphyn Biologics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alphyn Biologics, Inc.'s valuation, stock price, and market status.